Skip to main content

Table 2 Microorganism profile for the patients in the study cohort

From: Procalcitonin and C-reactive protein perform better than the neutrophil/lymphocyte count ratio in evaluating hospital acquired pneumonia

 

28-day survivors n = 235

28-day non-survivors n = 104

P value

Gram-positive isolates (n, %)

16 (6.8%)

11 (10.6%)

0.2772

S.Aureus

12 (5.1%)

10 (9.6%)

0.1505

MRSA

2 (0.9%)

0 (0)

1

Streptococcus spp.

1 (0.4%)

0 (0)

1

Enterococcus spp.

2 (0.9%)

1 (1.0%)

1

Other

1 (0.4%)

0 (%)

1

Gram-negative isolates (n, %)

158 (67.2%)

52 (50.0%)

0.0035

Acinetobacter baumannii

76 (32.3%)

37 (35.6%)

0.6175

Klebsiella spp.

59 (25.1%)

26 (25.0%)

1

Pseudomonas spp.

50 (21.3%)

13 (12.5%)

0.0687

Enterobacter spp.

24 (10.2%)

6 (5.8%)

0.2177

S. maltophilia

16 (6.8%)

3 (2.9%)

0.2018

Other

9 (3.8%)

4 (3.8%)

1

Fungi isolates (n, %)

55 (23.4%)

28 (26.9%)

0.4959

Candida albicans

28 (11.9%)

17 (16.3%)

0.2985

Candida glabrada

16 (6.8%)

2 (1.9%)

0.0702

Candida tropicalis

7 (3.0%)

4 (3.8%)

0.7423

Other

4 (1.7%)

4 (3.8%)

0.2556

Virus isolates (n, %)

2 (0.9%)

1 (1.0%)

1

Tuberculosis isolates (n, %)

1 (0.4%)

0 (0)

1

  1. Data were presented as number of isolates (percentage of current group), not number of patients. S. aureus, Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; S. maltophilia, Stenotrophomonas maltophilia; spp., species